fa analysis ratios fortis healthcare

8/11/2019 FA Analysis Ratios Fortis Healthcare

1/20

BALANCE SHEET AS AT MARCH 31, 2013

March 31, 2013 March 31, 2012

in Lacs in Lacs

EQUITY AND LIABILITIESShareholders funds

Share capital 40,953.37 40,950.61

Reserves and surplus 279,551.86 279,509.56

Total 320,505.23 320,460.17

Non-current liabilities

Long-term borrowings 69,743.33 67,978.23

Deferred tax liabilities (net) 31.84 0

Other long term liabilities 1,527.02 7,641.56

Long-term provisions 704.11 466.12

Total 72,006.30 76,085.91

Current liabilities

Short-term borrowings 30,056.49 42,266.05

Trade payables 4,734.31 4,637.61

Other current liabilities 19,758.32 5,882.22

Short-term provisions 765.76 417.27Total 55,314.88 53,203.15

TOTAL 447,826.41 449,749.23

ASSETS

Non-current assets

Fixed assets

Tangible assets 11,454.52 8,321.72Intangible assets 304.24 130.32

Capital work-in-progress 7,294.23 4,865.09

(i) Total 19,052.99 13,317.13


2/20

( ) , ,


3/20


March 31, 2013

in Lacs


Share capital 40,953.37 9.14%

Reserves and surplus 279,551.86 62.42%

Total 320,505.23 71.57%


Long-term borrowings 69,743.33 15.57%

Deferred tax liabilities (net) 31.84 0.01%

Other long term liabilities 1,527.02 0.34%

Long-term provisions 704.11 0.16%

Total 72,006.30 16.08%

Current liabilities

Short-term borrowings 30,056.49 6.71%

Trade payables 4,734.31 1.06%

Other current liabilities 19,758.32 4.41%

Short-term provisions 765.76 0.17%Total 55,314.88 12.35%

TOTAL 447,826.41 100%

ASSETS

Non-current assets

Fixed assets

Tangible assets 11,454.52 2.56%Intangible assets 304.24 0.07%

Capital work-in-progress 7,294.23 1.63%

(i) Total 19,052.99 4.25%


4/20

March 31, 2012

in Lacs

40,950.61 9.11%

279,509.56 62.15%

320,460.17 71.25%

0.00%

67,978.23 15.11%

0 0.00%

7,641.56 1.70%

466.12 0.10%

76,085.91 16.92%

0.00%

42,266.05 9.40%

4,637.61 1.03%

5,882.22 1.31%

417.27 0.09%53,203.15 11.83%

449,749.23 100.00%

8,321.72 1.85%130.32 0.03%

4,865.09 1.08%

13,317.13 2.96%


5/20

STATEMENT OF PROFIT AND LOSS FOR THE YEAR ENDED MARCH 31, 2013

March 31, 2013

in Lacs

INCOMERevenue from operations 35,297.21

Other income 19,056.93

Exceptional items 0

Total revenue 54,354.14

EXPENDITURE

Purchase of medical consumables and drugs (includes prior period items of ` 0.11 lacs,

Previous year ` 29 lacs) 10,187.06

Increase in inventories of medical consumables and drugs -51.39

Employee benefits expense 10,133.14

Other expenses 15,144.46

Total expenses 35,413.27

Earnings before interest, tax, depreciation and amortization (EBITDA) 18,940.87

Finance costs 13,386.47

Profit before tax, depreciation and amortization 5,554.40

Depreciation and amortization expense 2,346.83Profit before tax 3,207.57

Tax expense:

Current tax (including MAT payable) 1,450.85

Less: MAT credit entitlement 0

Deferred tax charge 31.84

Total tax expenses 1,482.69

Profit for the year 1,724.88Earnings per share [Nominal value of shares ` 10/- each (Previous year ` 10/- each)

Basic 0.43

Diluted 0.43


6/20

March 31, 2012

in Lacs

28,127.97

12,704.24

18,462.37

59,294.58

7,951.71

-95.56

7,073.50

12,721.55

27,651.20

31,643.38 1894087%

10,293.40 172488%

21,349.98

1,211.4420,138.54

4,030.45

-4,030.45

0

0.00

20,138.54

4.97

4.97


7/20


INCOMERevenue from operations

Total revenue

EXPENDITURE


Previous year ` 29 lacs)

Increase in inventories of medical consumables and drugs

Employee benefits expense

Other expenses

Depreciation and amortization expense

Total expenses

Earnings before interest, tax, depreciation and amortization (EBITDA)

Profit before tax

Tax expense:

Current tax (including MAT payable)

Less: MAT credit entitlement

Deferred tax charge

Total tax expenses

Current Year Income Tax

Tax on Other Income

Tax on Finance costs


8/20

Average Total Assets

Average Investments

Operating Assets

return on assets

return on operating assets

Asset turnover

Operating asset turnover


9/20

March 31, 2013 March 31, 2012

in Lacs in Lacs

35,297.21 28,127.97

35,297.21 28,127.97

10,187.06 7,951.71

-51.39 -95.56

10,133.14 7,073.50

15,144.46 12,721.55

2,346.83 1,211.44

37,760.10 28,862.64

-2,462.89 -734.67

0.00 0.00

-2,462.89 -734.67

1,450.85 4,030.45

0 -4,030.45

31.84 0

1,482.69 0.00

1,482.69 0.00

6,183.02 4,121.89 Tax percentage 32.445

4,343.24 3,339.69


10/20

448,787.82 403,566.14

235,798.17 192,045.04

212,989.65 211,521.10

0.38% 1.90%

-0.99% 2.85%

7.87% 6.97%

16.57% 13.30%


11/20


March 31, 2013 March 31, 2012

in Lacs in Lacs


Share capital 40,953.37 40,950.61

Reserves and surplus 279,551.86 279,509.56

Total 320,505.23 320,460.17


Long-term borrowings 69,743.33 67,978.23

Deferred tax liabilities (net) 31.84 0

Other long term liabilities 1,527.02 7,641.56

Long-term provisions 704.11 466.12

Total 72,006.30 76,085.91

Current liabilities

Short-term borrowings 30,056.49 42,266.05

Trade payables 4,734.31 4,637.61

Other current liabilities 19,758.32 5,882.22

Short-term provisions 765.76 417.27Total 55,314.88 53,203.15

TOTAL 447,826.41 449,749.23

ASSETS

Non-current assets

Fixed assets

Tangible assets 11,454.52 8,321.72

Intangible assets 304.24 130.32

Capital work-in-progress 7,294.23 4,865.09

(i) Total 19,052.99 13,317.13


12/20

Change

Amount %

2.76 0%

42.30 0%

45.06 0%

1,765.10 3%

31.84

-6,114.54 -80%

237.99 51%

-4,079.61 -5%

-12,209.56 -29%

96.70 2%

13,876.10 236%

348.49 84%2,111.73 4%

-1,922.82 0%

3,132.80 38%

173.92 133%

2,429.14 50%

5,735.86 43%


13/20


March 31, 2013

in Lacs

INCOMERevenue from operations 35,297.21

Other income 19,056.93

Exceptional items 0

Total revenue 54,354.14

EXPENDITURE


Previous year ` 29 lacs) 10,187.06

Increase in inventories of medical consumables and drugs 51.39

Employee benefits expense 10,133.14

Other expenses 15,144.46

Total expenses 35,413.27

Earnings before interest, tax, depreciation and amortization (EBITDA) 18,940.87

Finance costs 13,386.47

Profit before tax, depreciation and amortization 5,554.40

Depreciation and amortization expense 2,346.83

Profit before tax 3,207.57

Tax expense:

Current tax (including MAT payable) 1,450.85Less: MAT credit entitlement 0

Deferred tax charge 31.84

Total tax expenses 1,482.69


14/20

March 31, 2012

in Lacs Amount %

28,127.97 7,169.24 25%

12,704.24 6,352.69 50%

18,462.37 -18,462.37 -100%

59,294.58 -4,940.44 -8%

7,951.71 2,235.35 28%

95.56 -44.17 -46%

7,073.50 3,059.64 43%

12,721.55 2,422.91 19%

27,651.20 7,762.07 28%

31,643.38 -12,702.51 -40%

10,293.40 3,093.07 30%21,349.98 -15,795.58 -74%

1,211.44 1,135.39 94%

20,138.54 -16,930.97 -84%

4,030.45 -2,579.60 -64%4,030.45 -4,030.45 -100%

0 31.84

0 1,482.69

Change


15/20

Profitability Ratios

Amounts in Rs. Lacs

Ratio Formula

A Return on Equity Profit After Tax 1,724.88 0.54%

Total Shareholders Funds 320,505.23

B Profit After Tax 1,724.88 4.89%

Sales 35,297.21

C Operating Profit Margin (%) NOPAT (2,105.80) -5.97%

Sales 35,297.21

D Return on Assets Profit After Tax 1,724.88 0.38%

Average Total Assets 448,787.82

Profit margin Profit After Tax 1,724.88 4.89%

Sales 35,297.21

Asset Turnover Ratio Sales 35,297.21 7.87%

Total Assets 448,787.82

* Profit excluding exceptional items

Also refer NOPAT sheet

Extended Dupont Analysis

Return on Equity Profit After Tax 1,724.88 0.54%

2012-2013

Net Profit Margin (%) or Return On Sales


16/20

Equity 320,505.23

Profit margin Profit After Tax 1,724.88 4.89%

Sales 35,297.21

Asset Turnover Ratio Sales 35,297.21 7.87%Total Assets 448,787.82

Leverage Total Assets 448,787.82 140.03%

Total Equity 320,505.23


17/20

Liquidity Ratios

Amounts in Rs. Lacs

Ratio Formula

A Current Ratio Total Current Assets 117,201.53 2.12 : 1 153,427.03 2.884 : 1

Total Current Liabilities 55,314.88 53,203.15

B Quick Test Ratio Current Assets- Inventory 116,716.67 2.11 : 1 153,001.74 2.876 : 1

Current Liabilites 55,314.88 53,203.15

C Inventory Turnover Ratio Sales 35,297.21 72.80 Times 28,127.97 66.14 Times

Inventory 484.86 425.29

D Inventory Holding Period No of days in a year 365 5.01 Days 365 5.52 Days

Inventory Turnover Ratio 72.80 66.14

E Debtors Turnover Ratio Sales Turnover 35,297.21 3.79 Times 28,127.97 4.50 Times

Sundry Debtors 9,305.03 6,249.50

F Debtors Holding Period No of days in a year 365 96.22 Days 365 81.10 Days

Debtors Turnover Ratio 3.79 4.50

2012-2013 2011-12


18/20

Solvency Ratios

Amounts in Rs. Lacs

Ratio Formula

A Debt to equity ratio Total Borrowings there are no loans taken by the company. Hence this ratio is not applicable to Fortis

Sharholders' Funds

B Liabilities to Equity Ratio Total Liabilities. 447,826.41 1.40 : 1 449,749.23 1.40 : 1

Sharholders' Funds 320,505.23 320,460.17

C Leverage Total Assets 447,826.41 1.40 : 1 449,749.23 1.40 : 1

Total Equity 320,505.23 320,460.17

D Interest Coverage Ratio PBIT(from pg.29) (2,462.89) (0.18) times (734.67) (0.07) times

Interest Expense 13,386.47 10,293.40

-

2011-12 2011-12


19/20

ealthcare


20/20

Capital Market Ratios

Amounts in Rs. Lacs

Ratio Formula

A Earnings Per Share

(a) Basic 0.43 4.97

(b) Diluted 0.43 4.97

B

C Price Earnings Ratio Market Price 466.1 1,083.95 409.9 82.47

Earnings Per Share 0.43 4.97

D Dividend Yield Ratio Dividend per Share 0 0.00% 0 0.00%

Market Price 466.1 409.9

2011-12 2010-11

fa analysis ratios fortis healthcare

Documents